Literature DB >> 15727727

Vulnerable plaque: definition, detection, treatment, and future implications.

Kerem Ozer1, Mehmet Cilingiroglu.   

Abstract

Atherosclerosis continues to account for significant morbidity and mortality in most of the world. The major proportion of atherosclerosis mortality is related to atherosclerotic coronary artery disease, yet there still is not an optimal method for making the diagnosis of vulnerable plaque in vivo. The search for such an undefined method, along with studies on amelioration of currently available technology, gains special significance when the association between the qualitative definition of lesions in an individual and cardiovascular risks are considered. We, therefore, start by defining the critical lesion of coronary atherosclerosis and review the advantages and potential for clinical use of various methods to detect the vulnerable plaque and comment on possible future implications in this field.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15727727     DOI: 10.1007/s11883-005-0034-0

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  53 in total

1.  Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study.

Authors:  M Asakura; Y Ueda; O Yamaguchi; T Adachi; A Hirayama; M Hori; K Kodama
Journal:  J Am Coll Cardiol       Date:  2001-04       Impact factor: 24.094

2.  Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.

Authors:  K Ohtsuki; K Akashi; Y Aoka; F G Blankenberg; S Kopiwoda; J F Tait; H W Strauss
Journal:  Eur J Nucl Med       Date:  1999-10

3.  Characterization of signal properties in atherosclerotic plaque components by intravascular MRI.

Authors:  W J Rogers; J W Prichard; Y L Hu; P R Olson; D H Benckart; C M Kramer; D A Vido; N Reichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-07       Impact factor: 8.311

4.  Identification of atherosclerotic plaque components with intravascular ultrasound elastography in vivo: a Yucatan pig study.

Authors:  Chris L de Korte; Marion J Sierevogel; Frits Mastik; Chaylendra Strijder; Johannes A Schaar; Evelyn Velema; Gerard Pasterkamp; P W Serruys; Anton F W van der Steen
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

Review 5.  Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death.

Authors:  A Farb; A P Burke; A L Tang; T Y Liang; P Mannan; J Smialek; R Virmani
Journal:  Circulation       Date:  1996-04-01       Impact factor: 29.690

6.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

7.  Comparison of intravascular ultrasonic findings after coronary balloon angioplasty evaluated in vitro with histology.

Authors:  A van der Lugt; E J Gussenhoven; T Stijnen; M van Strijen; E van Driel; F C van Egmond; R J van Suylen; H van Urk
Journal:  Am J Cardiol       Date:  1995-10-01       Impact factor: 2.778

8.  In vivo imaging of proteolytic activity in atherosclerosis.

Authors:  Jiqiu Chen; Ching-Hsuan Tung; Umar Mahmood; Vasilis Ntziachristos; Robert Gyurko; Mark C Fishman; Paul L Huang; Ralph Weissleder
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

Review 9.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more
  2 in total

Review 1.  Optical coherence tomography and its use in detection of vulnerable plaque.

Authors:  Mehmet Cilingiroglu; Kerem Ozer
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

2.  Atherosclerosis: an integrative East-west medicine perspective.

Authors:  Hao Xu; Dazhuo Shi; Keji Chen
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-05       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.